Mostrando 4 resultados de: 4
Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient
ArticleAbstract: A 30-year-old male patient with paranoid schizophrenia was on clozapine therapy for more than five yPalabras claves:Autores:Adrián LLerena, Berecz R., De la Rubia A., Degrell I., Glaub T., Kellermann M.Fuentes:scopusRelationship between clozapine plasma levels and withdrawal symptoms
ArticleAbstract: Discontinuation of clozapine and an attempt to change his medication to sertindol has led to seriousPalabras claves:Clozapine, pharmacokinetics, Withdrawal symptomsAutores:Adrián LLerena, Berecz R., De La Rubia Martínez A., Degrell I., Glaub T., Gutiérrez Casares J., Norberto Gamero M.Fuentes:scopusRelationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients
ArticleAbstract: The implication of cytochrome P450 CYP2D6 enzyme activity in the metabolism of the antipsychotic druPalabras claves:Autores:Adrián LLerena, Berecz R., De la Rubia A., Degrell I., Dorado P., Gómez J., Kellermann M.Fuentes:scopusThe role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactions
ReviewAbstract: In the recent years it has been increasingly recognized that pharmacogenetical factors play an imporPalabras claves:CYP2D6, CYP3A4, metabolism, pharmacogenetics, RisperidoneAutores:Adrián LLerena, Berecz R., Cáceres M.C., De la Rubia A., Degrell I., Dorado P.Fuentes:scopus